Search This Blog

Wednesday, August 16, 2023

Strathspey Clarifying Statement Re Form 4 Filing for Holdings in AEON Biopharma

 The 7,380,394 AEON shares reflected in the Form 4 filed on August 14th were transferred to limited partners of Strathspey Crown

Strathspey Crown did not sell any AEON shares to the public as part of this transaction
All shares transferred to limited partners continue to be subject to restrictions on transfer under securities laws and a significant portion are also subject to a 12-month lockup expiring July 21, 2024 as provided in AEON’s bylaws

Strathspey Crown intends to file a Schedule 13D/A in the coming days to reflect the same transaction and show its remaining holdings of 2,031,773 AEON shares

https://finance.yahoo.com/news/strathspey-crown-holdings-group-llc-110000217.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.